Comparison of Drug-Eluting Stents and Bare-Metal Stents for the Treatment of Unprotected Left Main Coronary Artery Disease in Acute Coronary Syndromes

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 187-193

  Tamburino, Corrado ^a   Di Salvo, Maria Elena ^a   Capodanno, Davide ^a   Palmerini, Tullio ^b   Sheiban, Imad ^c   Margheri, Massimo ^d   Vecchi, Giuseppe ^e   Sangiorgi, Giuseppe ^f   Piovaccari, Giancarlo ^g   Bartorelli, Antonio ^h   Briguori, Carlo ⁱ   Ardissino, Diego ^j   Di Pede, Francesco ^k   Ramondo, Angelo ^l   Inglese, Luigi ^m   Petronio, Anna Sonia ⁿ   Bolognese, Leonardo ^m   Benassi, Alberto ^o   Palmieri, Cataldo ^p   Filippone, Vincenzo ^q   De Servi, Stefano ^r   more..

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Divisione di Cardiologia   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^f EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^g OSPEDALE DEGLI INFERMI   (Italy)

^h CENTRO CARDIOLOGICO MONZINO   (Italy)

ⁱ Clinica Mediterranea   (Italy)

^j UNIVERSITY HOSPITAL OF PARMA   (Italy)

^k Ospedale Civile   (Italy)

^l UNIVERSITY OF PADOVA   (Italy)

^m IRCCS POLICLINICO SAN DONATO   (Italy)

ⁿ CISANELLO HOSPITAL   (Italy)

^o HESPERIA HOSPITAL   (Italy)

^p CNR   (Italy)

^q VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^r Ospedale Civile   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART EJECTION FRACTION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 58149474652     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.059     Document Type: Article

References (13)

1. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., Chaitman B., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
2. Ong A.T., Serruys P.W., Mohr F.W., Morice M.C., Kappetein A.P., Holmes Jr. D.R., Mack M.J., van den Brand M., Morel M.A., van Es G.A., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151 (2006) 1194-1204
3. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
4. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., and Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting stents versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
5. Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Jüni P., Sianos G., Hellige G., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
6. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
7. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
8. Jaffe R., and Strauss B.H. Late and very late thrombosis of drug-eluting stents. J Am Coll Cardiol 50 (2007) 119-127
9. Gao R.L., Xu B., Chen J.L., Yang Y.J., Qiao S.B., Li J.J., Qin X.W., Yao M., Liu H.B., Wu Y.J., Yuan J.Q., and Chen J. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. Am Heart J 155 (2008) 553-561
10. Braunwald E., Angiolillo D., Bates E., Berger P.B., Bhatt D., Cannon C.P., Furman M.I., Gurbel P., Michelson A.D., Peterson E., and Wiviott S. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clin Cardiol 31 (2008) I17-I20
11. Valgimigli M., van Mieghem C.A.G., Ong A.T.L., Aoki J., Rodriguez Granillo G.A., McFadden E.P., Kappetein A.P., de Feyter P.J., Smits P.C., Regar E., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
12. Park S.J., Hong M.K., Lee C.W., Kim J.J., Song J.K., Kang D.H., Park S.W., and Mintz G.S. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 38 (2001) 1054-1060
13. Agostoni P., Valgimigli M., Van Mieghem C.A., Rodriguez-Granillo G.A., Aoki J., Ong A.T., Tsuchida K., McFadden E.P., Ligthart J.M., Smits P.C., et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 95 (2005) 644-647